Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 28-Sep-20 5:19 PM View:  | Wolff Stefani Chief Development Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 13,592 | $100.00 | $1,359,200.00 | (100%) 13.59K to 0 | |
| 28-Sep-20 5:11 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 3,302 | $100.00 | $330,200.00 | (100%) 3.3K to 0 | |
| 28-Sep-20 5:07 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 1,023 | $100.00 | $102,300.00 | (2%) 58.56K to 57.53K | |
| 28-Sep-20 5:14 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 1,916 | $100.00 | $191,600.00 | (100%) 1.92K to 0 | |
| 28-Sep-20 5:08 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 31,826 | $100.00 | $3,182,600.00 | (100%) 31.83K to 0 | |
| 28-Sep-20 5:27 PM View: | George Simeon Director | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 2,982,860 | $100.00 | $298,286,016.00 | (100%) 2.98M to 0 | |
| 28-Sep-20 5:07 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 57,534 | $100.00 | $5,753,400.00 | (100%) 57.53K to 0 | |
| 28-Sep-20 5:16 PM View: | Thomas Dolca Chief Medical Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 2,207 | $100.00 | $220,700.00 | (100%) 2.21K to 0 | |
| 28-Sep-20 5:24 PM View: | Becker Daniel J. Director | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 667,600 | $100.00 | $66,760,000.00 | (100%) 667.6K to 0 | |
| 28-Sep-20 5:11 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 3,799 | $100.00 | $379,900.00 | (53%) 7.1K to 3.3K | |
| 28-Sep-20 5:14 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 28-Sep-20 | Disposition (change in control) | 117,761 | $100.00 | $11,776,100.00 | (98%) 119.68K to 1.92K | |
| 28-Sep-20 5:19 PM View: | Wolff Stefani Chief Development Officer | Principia Biopharma Inc. (PRNB) | 18-Sep-20 | Gift | 5,504 | -- | -- | (29%) 19.1K to 13.59K | |
| 22-Sep-20 8:02 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 18-Sep-20 | Option Exercise | 5,000 | $5.86 | $29,320.50 | 4% 119.68K to 124.68K | |
| 22-Sep-20 8:02 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 18-Sep-20 | Planned Option Sale | 5,000 | $99.98 | $499,918.00 | (4%) 124.68K to 119.68K | |
| 20-Aug-20 8:17 PM View: | Thomas Dolca Chief Medical Officer | Principia Biopharma Inc. (PRNB) | 18-Aug-20 | Option Exercise | 15,000 | $23.77 | $356,550.00 | 821% 1.83K to 16.83K | |
| 20-Aug-20 8:17 PM View: | Thomas Dolca Chief Medical Officer | Principia Biopharma Inc. (PRNB) | 18-Aug-20 | Planned Private Option Sale | 15,000 | $100.00 | $1,500,000.00 | (89%) 16.83K to 1.83K | |
| 20-Aug-20 8:01 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 18-Aug-20 | Planned Private Option Sale | 7,500 | $99.37 | $745,240.00 | (52%) 14.34K to 6.84K | |
| 20-Aug-20 8:01 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 18-Aug-20 | Option Exercise | 7,500 | $3.00 | $22,482.80 | 110% 6.84K to 14.34K | |
| 12-Aug-20 8:01 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 10-Aug-20 | Planned Private Option Sale | 6,000 | $88.61 | $531,665.00 | (16%) 37.74K to 31.74K | |
| 12-Aug-20 8:01 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 10-Aug-20 | Option Exercise | 6,000 | $3.11 | $18,631.80 | 19% 31.74K to 37.74K | |
| 17-Jul-20 8:01 PM View: | Thomas Dolca Chief Medical Officer | Principia Biopharma Inc. (PRNB) | 15-Jul-20 | Planned Private Option Sale | 15,000 | $80.07 | $1,201,070.00 | (89%) 16.83K to 1.83K | |
| 17-Jul-20 8:01 PM View: | Thomas Dolca Chief Medical Officer | Principia Biopharma Inc. (PRNB) | 15-Jul-20 | Option Exercise | 15,000 | $23.77 | $356,550.00 | 821% 1.83K to 16.83K | |
| 02-Jul-20 8:48 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 01-Jul-20 | Option Exercise | 7,500 | $4.54 | $34,065.00 | 100% 0 to 7.5K | |
| 02-Jul-20 8:48 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 01-Jul-20 | Planned Private Option Sale | 7,500 | $60.00 | $450,000.00 | (100%) 7.5K to 0 | |
| 25-Jun-20 8:07 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 23-Jun-20 | Option Exercise | 15,000 | $3.00 | $44,965.50 | 26% 58.34K to 73.34K | |
| 25-Jun-20 8:07 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 23-Jun-20 | Planned Private Option Sale | 15,000 | $61.86 | $927,889.00 | (20%) 73.34K to 58.34K | |
| 17-Jun-20 9:52 PM View: | Wolff Stefani Chief Development Officer | Principia Biopharma Inc. (PRNB) | 15-Jun-20 | Private Sale (Planned) | 5,504 | $60.75 | $334,385.00 | (22%) 24.6K to 19.1K | |
| 15-Jun-20 8:12 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 12-Jun-20 | Planned Private Option Sale | 5,000 | $61.16 | $305,788.00 | (4%) 124.68K to 119.68K | |
| 15-Jun-20 8:12 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 12-Jun-20 | Option Exercise | 5,000 | $4.72 | $23,618.00 | 4% 119.68K to 124.68K | |
| 21-May-20 8:01 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 19-May-20 | Private Sale (Planned) | 1,825 | $65.10 | $118,812.00 | (21%) 8.67K to 6.84K | |
| 21-May-20 8:01 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 19-May-20 | Option Exercise | 5,675 | $3.00 | $17,011.90 | 65% 8.67K to 14.34K | |
| 21-May-20 8:01 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 19-May-20 | Planned Private Option Sale | 5,675 | $65.10 | $369,456.00 | (40%) 14.34K to 8.67K | |
| 08-May-20 8:05 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 07-May-20 | Option Exercise | 6,000 | $3.00 | $17,986.20 | 19% 30.97K to 36.97K | |
| 08-May-20 8:05 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 07-May-20 | Planned Private Option Sale | 6,000 | $60.16 | $360,941.00 | (16%) 36.97K to 30.97K | |
| 05-May-20 8:07 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 05-May-20 | Option Exercise | 6,660 | $4.54 | $30,249.70 | 100% 0 to 6.66K | |
| 05-May-20 8:07 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 05-May-20 | Planned Private Option Sale | 6,660 | $60.00 | $399,600.00 | (100%) 6.66K to 0 | |
| 05-May-20 8:07 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 01-May-20 | Option Exercise | 840 | $4.54 | $3,815.28 | 100% 0 to 0.84K | |
| 05-May-20 8:07 PM View: | Colowick Alan Director | Principia Biopharma Inc. (PRNB) | 01-May-20 | Planned Private Option Sale | 840 | $60.07 | $50,456.70 | (100%) 0.84K to 0 | |
| 18-Mar-20 5:08 PM View: | Wolff Stefani Chief Development Officer | Principia Biopharma Inc. (PRNB) | 16-Mar-20 | Planned Private Option Sale | 5,504 | $46.15 | $254,031.00 | (13%) 41.11K to 35.61K | |
| 18-Mar-20 5:08 PM View: | Wolff Stefani Chief Development Officer | Principia Biopharma Inc. (PRNB) | 16-Mar-20 | Option Exercise | 5,504 | $4.54 | $24,999.20 | 15% 35.61K to 41.11K | |
| 17-Mar-20 5:08 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 13-Mar-20 | Option Exercise | 5,000 | $4.72 | $23,618.00 | 4% 118.82K to 123.82K | |
| 17-Mar-20 5:08 PM View: | Hardiman Roy C. Chief Business Officer | Principia Biopharma Inc. (PRNB) | 13-Mar-20 | Planned Private Option Sale | 5,000 | $48.56 | $242,816.00 | (4%) 123.82K to 118.82K | |
| 05-Mar-20 5:21 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 03-Mar-20 | Private Sale (Planned) | 15,000 | $63.47 | $952,083.00 | (21%) 72.53K to 57.53K | |
| 20-Feb-20 5:02 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 18-Feb-20 | Option Exercise | 2,500 | $3.00 | $7,494.25 | 19% 13.07K to 15.57K | |
| 20-Feb-20 5:02 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 18-Feb-20 | Planned Private Option Sale | 2,500 | $65.89 | $164,729.00 | (16%) 15.57K to 13.07K | |
| 20-Feb-20 5:02 PM View: | Chai Christopher Y Chief Financial Officer | Principia Biopharma Inc. (PRNB) | 18-Feb-20 | Private Sale (Planned) | 5,000 | $65.89 | $329,457.00 | (38%) 13.07K to 8.07K | |
| 12-Feb-20 7:03 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 10-Feb-20 | Option Exercise | 6,000 | $3.00 | $17,986.20 | 19% 30.97K to 36.97K | |
| 05-Mar-20 5:21 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 10-Feb-20 | Gift | 1,159 | -- | -- | (2%) 73.69K to 72.53K | |
| 12-Feb-20 7:03 PM View: | Goldstein David Chief Scientific Officer | Principia Biopharma Inc. (PRNB) | 10-Feb-20 | Planned Private Option Sale | 6,000 | $70.90 | $425,400.00 | (16%) 36.97K to 30.97K | |
| 05-Mar-20 5:21 PM View: | Babler Martin President, CEO Director | Principia Biopharma Inc. (PRNB) | 10-Feb-20 | Gift | 1,159 | -- | -- | 2% 72.53K to 73.69K |
